MarketPulse

capital raise

62 articles
GlobeNewswire Inc.GlobeNewswire Inc.··Na

Dianthus Therapeutics Raises $625M in Upsized IPO Offering to Fund Pipeline Expansion

Dianthus Therapeutics prices $625M upsized offering at $81/share to fund drug development and commercial readiness. Closing expected March 12, 2026.
DNTHbiotechclinical-stage
GlobeNewswire Inc.GlobeNewswire Inc.··Na

Xenon Pharma Raises $650M in Upsized Offering to Fund Pipeline Growth

Xenon Pharmaceuticals prices $650M upsized offering at $57/share with 10.5M shares. Proceeds fund pipeline acceleration; closes March 2026.
XENEpublic offeringcapital raise
GlobeNewswire Inc.GlobeNewswire Inc.··Bioxcel Therapeutics, Inc.

BioXcel Therapeutics Raises $8M via Direct Offering Amid Market Challenges

BioXcel Therapeutics raises $8M via direct offering of 4.5M shares at $1.739/share, with warrant modifications agreed, closing expected March 2026.
BTAIartificial intelligencewarrants
GlobeNewswire Inc.GlobeNewswire Inc.··Na

Calidi Biotherapeutics Raises $6M in Public Offering, Exercises Full Warrant Overallotment

Calidi Biotherapeutics closed a $6 million underwritten public offering, issuing 12.1 million shares and Series J, K, L warrants with $0.50 exercise prices.
CLDIwarrantspublic offering
GlobeNewswire Inc.GlobeNewswire Inc.··Na

AIM ImmunoTech Closes $1.8M Rights Offering to Fund Pancreatic Cancer Drug

AIM ImmunoTech closes $1.8M rights offering to advance Ampligen immunotherapy development for late-stage pancreatic cancer treatment.
AIMclinical trialswarrants
GlobeNewswire Inc.GlobeNewswire Inc.··Na

First Atlantic Nickel Raises $3.9M in Final Tranche to Fund Nickel Projects

First Atlantic Nickel closes $3.9M final funding round at $0.18/share, with strategic investor maintaining 9.9% stake to fund nickel exploration projects.
CRMLCRMLWprivate placementcapital raise
GlobeNewswire Inc.GlobeNewswire Inc.··Na

Maris-Tech Raises $2M via Direct Offering to Shore Up Working Capital

Maris-Tech raises $2M through registered direct offering of shares at $1.24, deploying capital for working capital and corporate operations.
MTEKMTEKWAI technologycapital raise
BenzingaBenzinga··Mohd Haider

Battalion Oil Surges 15% on Iran Tensions and $15M Capital Raise

Battalion Oil surges 15.79% after-hours on Iran tensions and announces $15M private placement at $5.50 per share.
BATLprivate placementcapital raise
The Motley FoolThe Motley Fool··Brett Schafer

AST SpaceMobile Stock Crashes 28.8% as $1B Funding Raises Dilution Concerns

AST SpaceMobile stock plunged 28.8% in February after raising $1 billion via convertible notes, as investors questioned its $35.4 billion valuation for a pre-revenue, money-losing company.
VZASTSVODspace technologycapital raise
GlobeNewswire Inc.GlobeNewswire Inc.··Na

Dave Inc. Prices $175M Zero-Coupon Convertible Notes Due 2031

Dave Inc. prices $175M convertible notes at 0% with 32.5% conversion premium, plans $70.5M share buyback using proceeds.
DAVEDAVEWcapital raiseneobank
GlobeNewswire Inc.GlobeNewswire Inc.··Na

MAIA Biotech Raises $30M in Public Offering to Fund Clinical Trials

MAIA Biotechnology closes $30M public offering of 20M shares at $1.50/share, funding clinical trials and operations.
MAIApublic offeringcommon stock
BenzingaBenzinga··Globe Newswire

AIM ImmunoTech Raises $1.8M Through Rights Offering as Biotech Seeks Capital

AIM ImmunoTech raises $1.8M through rights offering expiring March 3, 2026, providing working capital for ongoing immunotherapy operations.
AIMwarrantscapital raise
GlobeNewswire Inc.GlobeNewswire Inc.··Na

MAIA Biotech Raises $30M via Stock Offering to Fund Clinical Trials

MAIA Biotechnology prices $30M public offering at $1.50/share to fund clinical trials. Offering closes March 4, 2026.
MAIApublic offeringcommon stock
BenzingaBenzinga··Globe Newswire

Palvella Therapeutics Raises $230M in Upsized IPO to Fund Rare Disease Pipeline

Palvella Therapeutics closed $230M public offering at $125/share on February 27, 2026, fully exercising underwriter options to fund rare skin disease programs.
PVLAclinical-stagepublic offering
GlobeNewswire Inc.GlobeNewswire Inc.··Na

Duos Technologies Raises $65M Through Stock Offering to Fuel Data Center Expansion

Duos Technologies raises $65M through stock offering to expand its Edge Data Center business segment amid strong 288% revenue growth.
DUOTrevenue growthpublic offering
GlobeNewswire Inc.GlobeNewswire Inc.··Anteris Technologies Global Corp.

Anteris Secures $320M Funding as DurAVR Heart Valve Advances to Global Trials

Anteris secures $320M funding to advance DurAVR heart valve through global trials, with FDA approval and increased clinical development spending.
MDTAVRFDA approvalclinical trial
BenzingaBenzinga··Globe Newswire

Bicara Therapeutics Raises $172.5M in Oversubscribed Offering

Bicara Therapeutics raises $172.5M in oversubscribed offering, with proceeds funding development of lead immunotherapy candidate ficerafusp alfa for solid tumors.
BCAXclinical-stageEGFR
BenzingaBenzinga··Prnewswire

Thesis Gold Secures C$44M in Strategic Funding from AngloGold Ashanti, Centerra Gold

Thesis Gold raises C$44M from AngloGold Ashanti and Centerra Gold to advance its Lawyers-Ranch gold-silver project in British Columbia.
AUCGAUprivate placementcapital raise
BenzingaBenzinga··Prnewswire

Brainstorm Cell Therapeutics Completes $2M February Fundraising Round

Brainstorm Cell Therapeutics raised $2M in February through private placement at $0.60/share. Funds support general operations, regulatory work, and Phase 3b trial preparations for ALS therapy NurOwn.
BCLIprivate placementcapital raise
BenzingaBenzinga··Globe Newswire

Larimar Therapeutics Raises $100M in Expanded Share Offering

Larimar Therapeutics raises $100M through expanded share offering at $5 per share, funding development of lead drug candidate nomlabofusp and operations.
LRMRpublic offeringcapital raise